Scancell Share Discussion Threads

[panama7] 19/9/2017 09:12

Goosed, we have every right to lambast Goodfellow, he has just raised funds at the lowest share price for 5 years at a time when vaccines are in vogue. He has spent the last 5 years decimating the share price left virtually every LTH sitting on losses and failed to deliver on all his statements and rhetoric. He has openly encouraged and coerced Chelsea into continually buying the share stating that everything is on track and going to plan when nothing could be further from the truth. We now have the SCIB1 vaccine sitting on the shelf doing nothing eating into it's use by date because the trials are running significantly late. He is simply out of his depth and is quite frankly his contempt and lack of respect for share holders points him out as a very nasty little man.

[gooosed] 18/9/2017 21:55

chelsea35 - yes and a reminder perhaps to those that continually lambast Richard Goodfellow :

“We couldn’t get any big pharmaceutical company to even talk to us about a cancer vaccine” while he was at the institute, Heery said, but now partnerships and deals involving vaccine-making biotechs are common.

“I don’t think that’s a coincidence,” he said. “I think they’re reading the tea leaves.”

Not sure about "common" but with the Moditope Patent - who knows ;-)

[chelsea35] 18/9/2017 20:08

Good to hear so soon after Bavarian Nordic.

[the real lozan] 18/9/2017 19:07

"May being a month = can be a month .."
May be, but it also 'CAN' fly.!!!

[chelsea35] 18/9/2017 18:04

Agree with that Lozan, not doubting we will get it at all, just the timelines. Odd day today, the bid fell from 12.8 to 12.725, and the ask 13.24 to 12.895 in one tick down.
Must be a hefty sell to come, but MMs still wanting shares? Not so easy to read on a volume of 248!!!

[the real lozan] 18/9/2017 15:46

One could say = "The RISKS here are 'PATENTLY' clear"

[inanaco] 18/9/2017 15:44

May being a month = can be a month ...

[tosh123] 18/9/2017 15:38

????????????????????????? No point debating "may" ... as that can also mean "can"

Surely you mean " no point debating "may" ... as that may also mean " can ".

[tosh123] 18/9/2017 15:35

I don't need to debate the meaning of " can ", the Oxford dictionary already does that most eloquently.

[inanaco] 18/9/2017 15:15

so Tosh and Herbie are One .... LOL

[inanaco] 18/9/2017 15:14

Gazza

No point debating "may" ... as that can also mean "can" .. according to Tosh

so that's best left with Tosh to explain

I see it as may be allowable once the Patent is fully processed as this is not the area of dispute.

[tosh123] 18/9/2017 15:10

Wanderer... that made me laugh out loud... great post.
Sums up in a couple of lines, just how idiotic a certain persons posts are.

[tosh123] 18/9/2017 15:09

Gazza, once again, you are 100% correct, and therefore by definition, the risks are " investment risks " NOT personal risks.
The village idiot has ONCE AGAIN, painted himself into a corner and destroyed his own flawed argument, its like taking candy from a baby. Still, at least he clearly now accepts that his statement is totally misleading and WRONG.

[wanderer1210_0] 18/9/2017 15:07

I wonder where Legal and General have filed these sharesHigh RiskModerate RiskLow Risk or of courseNo RiskI know where my tenner lies lol

[inanaco] 18/9/2017 15:01

Gazza, Its already priced in ... the share knows about the patent today ... its been in an RNS ..

[bermudashorts] 18/9/2017 14:59

Drdobson and Tosh - are you related? Your posting style is very similar.

[inanaco] 18/9/2017 14:59

Tosh who are you preaching to ?? Herbie ?

[gazza] 18/9/2017 14:58

Tosh,
As Inanaco quotes the patent office "MAY be allowable".

When you do a risk assessment you take into account both the likelyhood of the risk and the CONSEQUENCES. As far the Moditope patent goes, even if the likelyhood of being rejected was low, the consequences would be catastrophic as far as the share price goes - ignore this at your peril. AIMO of course.

[inanaco] 18/9/2017 14:56

nice simple post ....

I am sure Legal and General have more advanced investment managers, Than teams of Mr W's ... with gambling habits

[tosh123] 18/9/2017 14:52

Gazza,
you are quite right, until the full patent is granted and registered, there is a risk that it won't be accepted, and for the record " YET AGAIN " , there is a massive amount of investment risk here, as there is with any Baby Bio, or indeed any AIM listed stock.... FACT.
This risk IS NOT personal risk, it is COMPANY risk .... they are two totally separate things, anyone who tries to tell anyone different, clearly knows absolutely nothing.

IP has " potential "... until that " potential " is realised, there are huge risks. As of now, Scancell still falls into the " potential " category.... eg High Risk. That high risk is attributed to the company, NOT to the individual, therefore it is by definition, investment risk.

[wanderer1210_0] 18/9/2017 14:51

Lol Legal and General paid £1.6m for 16m shares, it's akin to us mere mortals putting on a £10 double on the horses. If it comes in, it's a few more quid in the account, if it doesn't there's nothing lost. Wonder why they never went "all in"? PMSL

[inanaco] 18/9/2017 14:42

Early feedback from the European Patent Office suggests that broad patent claims for the Moditope® platform may be allowable

that's good enough for me .... because no dispute on that area.

[inanaco] 18/9/2017 14:37

Gazza, Moditope patent is complex as its a new field, however the broad patent has already been agreed, But Scancell has not stopped at a single patent. Hence quite a bit is being spent on further patents in this area. Clearly legal and general did not consider it an issue ...